Presbia Flexivue Microlens™ Implanted in More Than 1,000 Patients Worldwide

DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic medical device company and leader in near-vision restoration announced today that more than 1000 patients worldwide have been treated with the Presbia Flexivue Microlens™. “We are very pleased to announce this significant milestone,” said Todd Cooper, President and CEO of Presbia. “As we expand the commercialization of our Microlens into additional countries around the world, we are thrilled by the feedback we are receiving from